Dermapharm Holding SE

DMPHF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$171,998$162,686$115,176$121,195
Short-Term Investments$0$3,212$2,841$511
Receivables$153,811$117,555$129,440$105,005
Inventory$398,600$350,324$350,681$339,856
Other Curr. Assets$30,567$28,808$32,102$26,931
Total Curr. Assets$754,976$662,585$630,240$593,498
Property Plant & Equip (Net)$367,105$314,602$316,451$315,028
Goodwill$676,252$576,266$576,462$576,385
Intangibles$573,777$497,249$504,066$512,313
Long-Term Investments$112,094$99,939$21,035$82,285
Tax Assets$0$0$0$0
Other NC Assets-$1-$15,101$63,484$510
Total NC Assets$1,729,227$1,472,955$1,481,498$1,486,521
Other Assets$0$0$0$0
Total Assets$2,484,203$2,135,540$2,111,738$2,080,019
Liabilities
Payables$110,121$100,738$97,517$94,785
Short-Term Debt$90,946$84,613$79,509$89,935
Tax Payable$0$34,807$36,825$67,419
Deferred Revenue$0$0$0$0
Other Curr. Liab.$142,222$140,135$92,884$74,776
Total Curr. Liab.$343,290$360,293$306,735$326,915
LT Debt$1,095,311$924,947$0$889,677
Deferred Rev, NC$0$0$0$11,337
Deferred Tax Liab, NC$128,603$110,417$112,052$111,703
Other NC Liab.$158,549$134,395$1,050,725$132,092
Total NC Liab.$1,382,464$1,169,759$1,162,777$1,144,809
Other Liabilities$0$0$0$0
Cap. Leases$0$19,767$0$17,470
Total Liabilities$1,725,754$1,530,052$1,469,512$1,471,724
Equity
Pref Stock$0$0$0$0
Common Stock$63,178$53,840$53,840$53,840
Retained Earnings$562,107$437,800$466,596$433,191
AOCI$18,267$0$0$0
Other Equity$118,272$116,608$118,124$117,391
Total Equity$761,824$608,248$638,560$604,422
Supplemental Information
Minority Interest-$3,375-$2,760$3,666$3,873
Total Liab. & Tot. Equity$2,484,203$2,135,540$2,111,738$2,080,019
Net Debt$1,014,259$846,874-$35,667$858,417
Dermapharm Holding SE (DMPHF) Financial Statements & Key Stats | AlphaPilot